Skip to main content

Animations

MJFF Publications

6411 - 6420 of 8801 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2014
  • 2024
  • 2018
  • 2025
  • 2025
  • 2025
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.009
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.3c11463
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Ipsilateral Association Between Rest Tremor and Striatal Binding Is Likely Spurious
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.30099
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Frailty in prodromal Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107965
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaques
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00938-9
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Hope vs. Hype I: It is time to redefine and rename Parkinson disease based on alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107983
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.838674
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Targeting LRRK2 mRNA stability in Parkinson’s disease
    Journal Name: Trends in Neurosciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.